Entering the Clinical Laboratory Testing Business: Is it Better to Buy or to Build?

For two decades, popular wisdom says “buy,’ but several entrepreneurs succeeded by building a brand new clinical lab company Over the past 15 years, there have been few examples of pathologists and medical laboratory executives willing to start up a new clinical laboratory company from scratch. The popular wisdom says that this is a next-to-impossible task. The same popular wisdom says that buying an existing clinical laboratory company is the best way for entrepreneurs and new investors to...

Thermo Fisher Trumped by Merck KGaA’s $7.2 Billion Bid to Acquire Millipore

Clinical Pathology Laboratory Customers of Millipore Not Likely to See Many Changes It only took a few days for Millipore Corporation (NYSE: MIL) to find a buyer willing to outbid Thermo Fisher Scientific Inc. (NYSE: TMO). Millipore agreed to be acquired by Merck KGaA (FWB: MRK) of Darmstadt, Germany. Merck will pay about $7.2 billion for Millipore, which tops a reported bid of $6 billion made by Thermo Fisher last week. Because many clinical pathology laboratories use Millipore’s water...

Sonic Healthcare Enters New England with Latest Clinical Laboratory Acquisition

Agreement to acquire East Side Clinical Laboratory is a reminder that Sonic remains an active buyer of clinical laboratories It’s another clinical lab acquisition and a new regional market for Sonic Healthcare Limited (ASX:SHL). Yesterday the Australian-based lab company established a beachhead in New England when it acquired East Side Clinical Laboratory, based in Providence, Rhode Island. East Side is the third laboratory acquisition that Sonic Healthcare made during 2009. Sonic officials...
;